We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares

69 hedge funds and large institutions have $104M invested in NovaBridge Biosciences American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

688% more call options, than puts

Call options by funds: $134K | Put options by funds: $17K

5% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 20

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3.1% less ownership

Funds ownership: 16.18%13.08% (-3.1%)

8% less funds holding

Funds holding: 7569 (-6)

16% less capital invested

Capital invested by funds: $123M → $104M (-$19.6M)

40% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 15

Holders
69
Holders Change
-6
Holders Change %
-8%
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
21
Reduced
20
Closed
15
Calls
$134K
Puts
$17K
Net Calls
+$117K
Net Calls Change
+$131K
Name Holding Trade Value Shares
Change
Change in
Stake
Handelsbanken Fonder
26
Handelsbanken Fonder
Sweden
$504K
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$493K +$17.6K +4,637 +4%
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$446K -$226K -59,760 -36%
MCP
29
Maso Capital Partners
Hong Kong
$418K
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$408K +$23.9K +6,325 +7%
Invesco
31
Invesco
Georgia
$313K +$443 +117 +0.2%
Jane Street
32
Jane Street
New York
$308K +$279K +73,672 New
EFM
33
E Fund Management
China
$263K -$148K -39,195 -38%
AA
34
ALPS Advisors
Colorado
$236K +$42.8K +11,301 +25%
Citigroup
35
Citigroup
New York
$232K +$145K +38,207 +221%
Geode Capital Management
36
Geode Capital Management
Massachusetts
$224K +$90.3K +23,855 +80%
Renaissance Technologies
37
Renaissance Technologies
New York
$197K -$432K -114,000 -71%
HF
38
HRT Financial
New York
$157K +$143K +37,741 New
DC
39
Diametric Capital
Massachusetts
$154K +$30K +7,934 +27%
VEA
40
Virtus ETF Advisers
New York
$152K +$94.4K +24,945 +216%
N
41
Nuveen
North Carolina
$140K -$147K -38,700 -54%
CSS
42
Cubist Systematic Strategies
Connecticut
$122K +$46.4K +12,243 +73%
Connor, Clark & Lunn Investment Management (CC&L)
43
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$113K +$103K +27,113 New
PCM
44
Prelude Capital Management
New York
$111K +$41.7K +11,024 +71%
E
45
Ergoteles
New York
$81.5K +$73.8K +19,500 New
Squarepoint
46
Squarepoint
New York
$70.6K -$188K -49,546 -75%
CANY
47
Caxton Associates (New York)
New York
$70.2K +$63.6K +16,800 New
SG Americas Securities
48
SG Americas Securities
New York
$62K +$2.41K +637 +5%
Northern Trust
49
Northern Trust
Illinois
$54.5K -$2.81K -742 -5%
Mariner
50
Mariner
Kansas
$52K +$47.2K +12,459 New

NBP Hedge Fund Activity: Q4 2022 in Review

69 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q4 2022, worth a combined $104M — down 16% from $123M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of NBP and 9 opened new positions — a net loss of 6 holders — while 20 trimmed existing stakes and 21 added.

The largest buyer was JP Morgan Chase, adding an estimated $2.92M. The largest seller was Nomura Holdings, cutting an estimated $8.22M.

  • 69 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q4 2022, down from 75 in Q3 2022.
  • Funds reported $104M of NovaBridge Biosciences American Depositary Shares stock for Q4 2022, down 16% quarter-over-quarter.
  • 9 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q4 2022 and 15 closed out, a net change of -6 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q4 2022 was JP Morgan Chase, an estimated $2.92M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q4 2022 was Nomura Holdings, an estimated $8.22M sold.

Based on aggregated 13F filings for Q4 2022.